Latest Share Chat

CLIN.L Share News (CLIN)

CLIN.L Information

There is currently no data for CLIN

Clinigen confirms takeover talks with Triton, shares surge

Thu, 02nd Dec 2021 12:59

(Sharecast News) - Clinigen shares surged on Thursday after the company confirmed it has received a non-binding indicative proposal from investment firm Triton about a possible offer.
Responding to press speculation, the AIM-listed pharmaceuticals services and products company said it was in advanced talks regarding the proposal and advised shareholders to take no action.

"There can be no certainty that any firm offer will be made for the company, nor as to the terms on which any firm offer might be made," it said.

At 1320 GMT, the shares were up 17.1% at 738.50p.

More News

7 Jul 2021 09:43

BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties

30 Jun 2021 13:07

Clinigen to sell UK specials business for up to £7.8m

(Sharecast News) - Pharmaceutical company Clinigen has agreed the disposal of its non-core UK specials manufacturing and aseptic compounding business to Target Healthcare for up to £7.75m.

30 Jun 2021 10:59

Clinigen to sell non-core UK Specials business for GBP7.8 million

18 Jun 2021 09:39

BROKER RATINGS: HSBC upgrades airlines Ryanair, Wizz and easyJet

9 Jun 2021 12:10

LONDON MARKET MIDDAY: Hesitation before risk events; Clinigen down 25%

9 Jun 2021 10:44

CORRECT: Clinigen slides 25% as Covid hits other hospital treatments

9 Jun 2021 10:37

AIM WINNERS & LOSERS: Clinigen shares dive as earnings outlook lowered

9 Jun 2021 09:31

BROKER RATINGS: Smith & Nephew gets upgrade while M&G receives cut

9 Jun 2021 09:21

TOP NEWS: Clinigen slides 20% as Covid hits other hospital treatments

9 Jun 2021 09:07

Clinigen FY underlying earnings impacted by decrease in products revenue

(Sharecast News) - Pharmaceutical firm Clinigen said on Wednesday that while net revenues were still expected to be in line with both guidance and expectations, full-year adjusted underlying earnings were now projected to be within the range of £114.0m and £117.0m due to a decrease in revenues from its products division.

9 Jun 2021 08:46

Latest Share Chat

CLIN.L Share News (CLIN)

Clinigen confirms takeover talks with Triton, shares surge

BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties

Clinigen to sell UK specials business for up to £7.8m

Clinigen to sell non-core UK Specials business for GBP7.8 million

BROKER RATINGS: HSBC upgrades airlines Ryanair, Wizz and easyJet

LONDON MARKET MIDDAY: Hesitation before risk events; Clinigen down 25%

CORRECT: Clinigen slides 25% as Covid hits other hospital treatments

AIM WINNERS & LOSERS: Clinigen shares dive as earnings outlook lowered

BROKER RATINGS: Smith & Nephew gets upgrade while M&G receives cut

TOP NEWS: Clinigen slides 20% as Covid hits other hospital treatments

Clinigen FY underlying earnings impacted by decrease in products revenue

LONDON MARKET OPEN: Stocks hover with sights set on US inflation

LONDON MARKET PRE-OPEN: UK competition regulator probes BA and Ryanair

UK dividends calendar - next 7 days

Tuesday broker round-up

Clinigen to supply Erwinase in UK in "milestone" with PBL partnership

Latest Share Chat

CLIN.L Share News (CLIN)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Clinigen confirms takeover talks with Triton, shares surge

Login to your account

Quickpicks are a member only feature

Login to your account